4//SEC Filing
Hodges Philip 4
Accession 0000899243-21-008691
CIK 0001326190other
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 7:00 PM ET
Size
6.7 KB
Accession
0000899243-21-008691
Insider Transaction Report
Form 4
Hodges Philip
Director
Transactions
- Sale
Common Stock, par value $0.0001
2021-03-01$16.08/sh−6,000$96,480→ 8,731 total
Holdings
- 17,848(indirect: See Footnote)
Common Stock, par value $0.0001
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.68 to $16.56, inclusive. The reporting person undertakes to provide to Altimmune, Inc., any security holder of Altimmune, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]The shares of Common Stock are owned directly by Paradigm Venture Partners, L.P. The reporting person has sole voting and dispositive control with respect to all securities held by Paradigm Venture Partners, L.P. and may be deemed to be the beneficial owner of the securities held by Paradigm Venture Partners, L.P. The reporting person disclaims beneficial ownership of the securities held by Paradigm Venture Partners, L.P. except to the extent of his pecuniary interest therein.
Documents
Issuer
Altimmune, Inc.
CIK 0001326190
Entity typeother
Related Parties
1- filerCIK 0001705562
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Mar 1, 7:00 PM ET
- Size
- 6.7 KB